Hypoxia imaging for head and neck cancer treatment planning
Part of Cancer clinical trials.
This study uses a special MRI scan to measure oxygen levels in your head and neck tumor. The goal is to learn if this scan can help doctors choose the best treatment plan for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a newly diagnosed head and neck squamous cell carcinoma (a common type of head and neck cancer).
- You must be scheduled to receive either chemoradiotherapy (chemotherapy plus radiation) or surgery.
- You cannot have had any prior treatment for head and neck cancer (surgery, radiation, or chemotherapy).
- You must not have any metal implants or devices that are not safe for MRI scans (like a pacemaker or cochlear implant).
- You must not have severe kidney problems (eGFR less than 30) or uncontrolled diabetes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a combined PET-MRI scan to measure how much oxygen a head and neck tumor has. It may help doctors understand tumor “oxygen levels,” which can relate to how tumors grow and respond to treatment.
This trial tests a way to personalize radiation treatment using a special scan (FMISO) to improve targeting in certain head and neck cancers. It is designed for people who are newly diagnosed and ready for standard curative (definitive) chemoradiation or faster radiation schedules.
This study tests whether giving lower doses of radiation and chemotherapy is safe and effective for people with certain head and neck cancers. It aims to reduce side effects while keeping the treatment successful.
This trial uses a special PET scan tracer called 18F-FMISO to see areas of low oxygen (hypoxia) in your tumor. The results may help doctors adjust your radiation plan to target those areas more precisely.
This Phase 2 trial tests whether planning radiation based on an imaging scan (F-MISO PET) can better target oxygen-poor (low-oxygen) tumor areas in head and neck cancer. It may help make radiation more precise while still using standard curative treatment.
This trial studies whether a brain PET scan using a medicine called FMISO can help show how active certain brain tumors are. It mainly aims to see if the scan is practical and useful in planning care for people with suspected or known brain tumors.
Hear when a new Head and Neck Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.